Credit Suisse’s Calello takes break for treatment

Eric Varvel is to take over as acting chief executive of Credit Suisse’s investment bank arm after Paul Calello steps down temporarily for medical treatment. Varvel retains his duties as chief executive of the Europe, Middle East and Asia region based in London. Calello plans to remain as involved as he can be in the business during his treatment.

  • 04 Sep 2009

Please take a trial or subscribe to access this content.

Contact our subscriptions team to discuss your access: subs@globalcapital.com

Corporate access

To discuss GlobalCapital access for your entire department or company please contact our subscriptions sales team at: subs@globalcapital.com or find out more online here.

All International Bonds

Rank Lead Manager Amount $m No of issues Share %
  • Last updated
  • Today
1 Citi 304,500.91 1183 8.04%
2 JPMorgan 297,722.75 1300 7.86%
3 Bank of America Merrill Lynch 278,326.06 937 7.35%
4 Barclays 230,841.51 858 6.10%
5 Goldman Sachs 206,469.72 679 5.45%

Bookrunners of All Syndicated Loans EMEA

Rank Lead Manager Amount $m No of issues Share %
  • Last updated
  • Today
1 BNP Paribas 43,227.81 174 7.04%
2 JPMorgan 38,825.76 78 6.32%
3 Credit Agricole CIB 33,071.14 158 5.38%
4 UniCredit 32,366.25 145 5.27%
5 SG Corporate & Investment Banking 31,330.98 120 5.10%

Bookrunners of all EMEA ECM Issuance

Rank Lead Manager Amount $m No of issues Share %
  • Last updated
  • Today
1 JPMorgan 13,024.03 55 8.90%
2 Goldman Sachs 12,162.67 59 8.31%
3 Citi 9,480.20 54 6.48%
4 Morgan Stanley 8,083.13 49 5.52%
5 UBS 7,976.88 32 5.45%